Viewing Study NCT06541704

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:14 PM
Ignite Modification Date: 2026-02-28 @ 11:21 AM
Study NCT ID: NCT06541704
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2024-08-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Sponsor: Regeneron Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Age-related Macular Degeneration (AMD) View
None Geographic Atrophy (GA) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GA secondary to AMD View